- Joined
- Mar 23, 2002
- Messages
- 1
- Reaction score
- 0
I have done an elective in Rad Onc and have decided that I definately like the field and could see myself doing it for a living. Of course that is in regards to the current state of the field. I know this has been touched upon on this site before but I am really concerned about the future of the field.
It seems like degree of specialty of the field has left it little room for adaptability, and Rad Oncs don't seem too aggressive to claim newer treatments such as radioisotopes for throid cancer.
XRT is so non-specific and the Gamma knife hasn't turned out to be the saving grace as expected. Does anyone have some advice on where the fiueld is heading and new developments on the horizon that will allow it to compete with newer more specific treatments?
No one can predict the future, but I worry that in 30 years when I still hope to be practicing that there may no longer be a role for Rad Onc in the treatment of cancer. After 4 years of busting my butt in medical school and the prospect of training 4 more years in residency I would hate to be phased out during my career.
Any Thoughts?
It seems like degree of specialty of the field has left it little room for adaptability, and Rad Oncs don't seem too aggressive to claim newer treatments such as radioisotopes for throid cancer.
XRT is so non-specific and the Gamma knife hasn't turned out to be the saving grace as expected. Does anyone have some advice on where the fiueld is heading and new developments on the horizon that will allow it to compete with newer more specific treatments?
No one can predict the future, but I worry that in 30 years when I still hope to be practicing that there may no longer be a role for Rad Onc in the treatment of cancer. After 4 years of busting my butt in medical school and the prospect of training 4 more years in residency I would hate to be phased out during my career.
Any Thoughts?